Science Explorer Back to mapMap
Discussion
Researcher · Abbott Fund · United States

Michael J. Mitten

Michael J. Mitten publishes mostly in Molecular Biology, Oncology and Epidemiology, on topics such as Cell death mechanisms and regulation, Cancer therapeutics and mechanisms and Pneumonia and Respiratory Infections.

OpenAlex
World rank
#266,331
of 7,710,434 ranked researchers
Rank in United States
#97,471
of 1,627,098
Works
100
Citations
12k
Citations per work
121.2
h-index
25
i10-index 34Top 22% in Molecular Biology
Michael J. Mitten

What does Michael J. Mitten research?

Michael J. Mitten's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (30%), Chemistry (7%).

Health Sciences: 33 works · 33.3% of their workMedicine: 33 works · 33.3% of their workOncology: 14 works · 14.2% of their workEpidemiology: 10 works · 10.0% of their workHematology: 6 works · 5.8% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 3.3% of their workEverything else: 30 works · 30.0% of their workLife Sciences: 30 works · 30.0% of their workBiochemistry, Genetics and Molecular Biology: 30 works · 30.0% of their workMolecular Biology: 30 works · 30.0% of their workPhysical Sciences: 7 works · 6.7% of their workChemistry: 7 works · 6.7% of their workOrganic Chemistry: 7 works · 6.7% of their workTHEIR WORKMichael J. Mitten100works
Life Sciences30%Physical Sciences7%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3333.3%
  2. Everything else3030.0%
    1. Biochemistry, Genetics and Molecular Biology3030.0%
    1. Chemistry76.7%
  1. 1Molecular Biology30% of their works
  2. 2Oncology14% of their works
  3. 3Epidemiology10% of their works
  4. 4Organic Chemistry7% of their works
  5. 5Hematology6% of their works
  6. 6Radiology, Nuclear Medicine and Imaging3% of their works

Research topics

Which keywords describe Michael J. Mitten's research?

The keywords of their largest research topics: Apoptosis, Cancer Therapy, Bcl-2 Family, Cell Death, Chemotherapy, Epidemiology, Community-Acquired Pneumonia and DNA.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Apoptosis152 topics
  2. Cancer Therapy152 topics
  3. Bcl-2 Family111 topic
  4. Cell Death111 topic
  5. Chemotherapy112 topics
  6. Epidemiology102 topics
  7. Community-Acquired Pneumonia61 topic
  8. DNA61 topic
  9. Pneumococcal Conjugate Vaccine61 topic
  10. Topoisomerases61 topic
  11. Breast Cancer51 topic
  12. Diagnosis Criteria51 topic
  13. HER251 topic
  14. International Myeloma Working Group51 topic
  15. Cell Cycle41 topic
  16. Fc Receptors41 topic
  17. Pneumocystis41 topic
  18. Pneumonia41 topic
  19. Therapeutic Antibodies41 topic
  20. p5341 topic

Where does Michael J. Mitten work?

Michael J. Mitten's main affiliation in the publication record is Abbott Fund, United States.

How many publications and citations does Michael J. Mitten have?

OpenAlex counts 100 works and 12,121 citations for Michael J. Mitten, an h-index of 25, ranking #266,331 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michael J. Mitten. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.